The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The purpose of accreditation is to set quality practice standards and certify facilities that meet them, according to Dr. Harvey Neiman, ACR executive director. The peer-reviewed assessments include an evaluation of personnel qualifications, equipment performance, and image quality, as well as standards and protocols for quality assurance and quality control.
"The ACR is extremely proud to do its part to help ensure that our nation's veterans receive the highest quality healthcare available," Neiman said.
The college brings considerable experience to the assignment. About 200 radiation oncology facilities in the U.S. have either been accredited or are going through the ACR accreditation process. As with nongovernment facilities, the accreditation process for the VA services will involve both self-assessment and independent external expert audits, based on ACR guidelines and technical standards.
ACR accreditation requires that the physicians providing radiation therapy to patients meet specific education and training standards. It also mandates that the equipment be inspected regularly by qualified medical physicists and that the radiation therapists administering the treatments be appropriately certified.
In addition to radiation oncology, the ACR manages accreditation programs for MRI, CT, nuclear medicine, PET, diagnostic ultrasound, radiation oncology, stereotactic breast biopsy, mammography, and breast ultrasound. About 16,000 facilities have earned ACR accreditation, Neiman said.
For more information from the Diagnostic Imaging archives:
Proponents hail pass of Medicare bill as triumph for physicians, patients
FDA panel recommends adding stereotactic breast biopsy to quality standards program
Consultant describes how MRI services can meet accreditation deadline
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.